Data as of Sep 19
| -1.37 / -5.27%|
The 6 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 37.50, with a high estimate of 42.00 and a low estimate of 35.00. The median estimate represents a +52.32% increase from the last price of 24.62.
The current consensus among 6 polled investment analysts is to Buy stock in Hyperion Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.